Transplant outcomes after CPX-351 vs 7 1 3 in older adults with newly diagnosed high-risk and/or secondary AML

Geoffrey L. Uy; Laura F. Newell; Tara L. Lin; Stuart L. Goldberg; Matthew J. Wieduwilt; Robert J. Ryan; Stefan Faderl; Jeffrey E. Lancet

doi:10.1182/bloodadvances.2021006468

Transplant outcomes after CPX-351 vs 7 1 3 in older adults with newly diagnosed high-risk and/or secondary AML

Geoffrey L. Uy, Laura F. Newell, Tara L. Lin, Stuart L. Goldberg, Matthew J. Wieduwilt, Robert J. Ryan, Stefan Faderl, Jeffrey E. Lancet

Research output: Contribution to journal › Letter › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	4989-4993
Number of pages	5
Journal	Blood Advances
Volume	6
Issue number	17
DOIs	https://doi.org/10.1182/bloodadvances.2021006468
State	Published - Sep 13 2022

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/bloodadvances.2021006468

Cite this

@article{94aa6a7bdff54922ae6ed1749bce7d32,

title = "Transplant outcomes after CPX-351 vs 7 1 3 in older adults with newly diagnosed high-risk and/or secondary AML",

author = "Uy, {Geoffrey L.} and Newell, {Laura F.} and Lin, {Tara L.} and Goldberg, {Stuart L.} and Wieduwilt, {Matthew J.} and Ryan, {Robert J.} and Stefan Faderl and Lancet, {Jeffrey E.}",

year = "2022",

month = sep,

day = "13",

doi = "10.1182/bloodadvances.2021006468",

language = "English (US)",

volume = "6",

pages = "4989--4993",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "17",

}

TY - JOUR

T1 - Transplant outcomes after CPX-351 vs 7 1 3 in older adults with newly diagnosed high-risk and/or secondary AML

AU - Uy, Geoffrey L.

AU - Newell, Laura F.

AU - Lin, Tara L.

AU - Goldberg, Stuart L.

AU - Wieduwilt, Matthew J.

AU - Ryan, Robert J.

AU - Faderl, Stefan

AU - Lancet, Jeffrey E.

PY - 2022/9/13

Y1 - 2022/9/13

UR - http://www.scopus.com/inward/record.url?scp=85139023679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85139023679&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2021006468

DO - 10.1182/bloodadvances.2021006468

M3 - Letter

C2 - 35443022

AN - SCOPUS:85139023679

SN - 2473-9529

VL - 6

SP - 4989

EP - 4993

JO - Blood Advances

JF - Blood Advances

IS - 17

ER -

Transplant outcomes after CPX-351 vs 7 1 3 in older adults with newly diagnosed high-risk and/or secondary AML

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this